June 26, 2024

Two WSU cancer leaders named Health Care Heroes

Two members of the Wayne State University School of Medicine faculty were named 2024 Health Care Heroes by Crain’s Detroit Business.

Boris Pasche, M.D., Ph.D., FACP, chair of the Department of Oncology, and Michael Dominello, D.O., associate professor of Radiation Oncology, were both named by Crain’s to its annual list of those in health care who are making a difference.

Boris Pasche, M.D., Ph.D.

Dr. Pasche, president and chief executive officer of the Barbara Ann Karmanos Cancer Institute, was named an Advancements in Care Hero for his co-invention of the Therabionic P1 device. He and his co-inventor, Alexandre Barbault, started studying the use of low-level radiofrequency electromagnetic fields to treat cancer in the early 2000s.

“This is a systemic targeted therapy; it only targets the cancer cells,” Dr. Pasche told Crain’s. “There are no side effects. There’s no drop in blood counts, which is especially important for cancers like liver cancer. We think we’ve got something really special here.”

The P1 device was FDA-approved in September 2023 to treat advanced hepatocellular carcinoma, the most common type of liver cancer. By the end of the year, it will be available for patients at Karmanos. In addition, Karmanos researchers and scientists are studying the use of radiofrequency electromagnetic fields to treat other solid tumor cancers.

Dr. Pasche is a medical oncologist who specializes in gastrointestinal malignancies and hereditary cancer. In addition to his position as president and CEO, he is also Karmanos’s principal investigator of the National Cancer Institute’s Comprehensive Cancer Center Core Grant and a scientific member of the Molecular Therapeutics Research Program.

Read Dr. Pasche’s Health Care Heroes profile here.

Learn more about the P1 device here.

Dr. Dominello, medical director of Gamma Knife Radiosurgery, leader of the Neuro-Oncology Multidisciplinary Team and member of the Breast Cancer MDT at Karmanos, was named a Physician Hero. He has focused on incorporating and publishing novel treatments and techniques to improve patient outcomes, specifically for breast and brain cancer.

Michael Dominello, D.O.

A manuscript that Dr. Dominello wrote details an innovative radiation delivery method developed by his team at Karmanos to minimize incidental dose to the heart when treating left-sided breast cancers. This technique is now considered standard practice to keep the radiation dose to the heart at near-zero levels. Also, in the last three years, he has enrolled 25 patients in interventional clinical trials and 193 patients in prospective observational studies with patient-reported outcomes to learn how care teams can better care for patients.

Dr. Dominello was integral in bringing the only out-patient Gamma Knife radiosurgery system to the Karmanos Cancer Institute at Weisberg Cancer Center in Farmington Hills and designing the space for the machine. The machine treats brain tumors and neurological disorders. He and his team continue to study how to improve patient experience and outcomes with this non-invasive procedure, utilizing the most precise stereotactic radiosurgery system.

“The brain is very important real estate, and so selecting the optimal tool to treat that spot, that lesion, that tumor … that is a true advantage in cancer medicine,” Dr. Dominello told Crain’s.

Dr. Dominello also is a scientific member of the Molecular Imaging Research Program.

Read Dr. Dominello’s Health Care Heroes profile here.

Learn more about Gamma Knife here.

This article originally published here.

Subscribe to Today@Wayne

Direct to your inbox each week